The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study

The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study

Objective: This study was designed to evaluate the effects of 3 mg drospirenone/30 μg ethinyl estradiol (OC) alone or combined with 1700 mg metformin on metabolic risk factors. Materials and methods: In this randomized, prospective, controlled study, 87 non-obese (18–30 BMI) women of reproductive ag...

Full description

Bibliographic Details
Main Authors:	Serkan Bodur, Ozgur Dundar, Mine Kanat-Pektas, Mehmet Ferdi Kinci, Levent Tutuncu
Format:	Article
Language:	English
Published:	Elsevier 2018-06-01
Series:	Taiwanese Journal of Obstetrics & Gynecology
Subjects:	Polycystic ovary syndrome Oral contraceptives Drospirenone Metformin Metabolic syndrome
Online Access:	http://www.sciencedirect.com/science/article/pii/S1028455918300810

Similar Items

Treatment of adolescent girls with polycystic ovary syndrome and insulin resistance
by: E. M. Bogatyreva, et al.
Published: (2018-07-01)

Comparison of Drospirenone- with Cyproterone Acetate-Containing Oral Contraceptives, Combined with Metformin and Lifestyle Modifications in Women with Polycystic Ovary Syndrome and Metabolic Disorders: A Prospective Randomized Control Trial
by: Qiu-Yi Wang, et al.
Published: (2016-01-01)

Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome
by: Ferdous Mehrabian, et al.
Published: (2016-01-01)

The effect of metformin treatment on ICSI in infertile polycystic ovary syndrome
by: Firoozeh Akbari Asbagh, et al.
Published: (2010-03-01)

Pregnancy in polycystic ovary syndrome
by: Sadishkumar Kamalanathan, et al.
Published: (2013-01-01)

Metformin Improves the Depression Symptoms of Women with Polycystic Ovary Syndrome in a Lifestyle Modification Program
by: AlHussain F, et al.
Published: (2020-04-01)

Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome
by: Veena Singh
Published: (2012-01-01)

COMPARISON OF METFORMIN AND ORAL CONTRACEPTIVE PILLS IN THE TREATMENT OF POLYCYSTIC OVARIAN SYNDROME
by: Rabia Mushtaq, et al.
Published: (2021-08-01)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
by: Karoon Shahebrahimi, et al.
Published: (2016-01-01)

Retrospective Analysis of the Effect Metformin Use and Lifestyle Modifications Have on Conception and Live Birth in Polycystic Ovary Syndrome
by: Smith, Kimberly M., et al.
Published: (2008)

The effect of metformin on uteroplacental circulation and pregnancy outcomes in pregnant women with Polycystic Ovary Syndrome
by: Jamal A, et al.
Published: (2010-07-01)

Effect of Metformin Therapy on the Levels of Folic Acid and Homocysteine in Women with Polycystic Ovary Syndrome
by: Yu.I. Karachentsev, et al.
Published: (2016-02-01)

Effects of Metformin Treatment on Homocysteine Levels and Metabolic Parameters of Women With Polycystic Ovary Syndrome
by: Soheila Riahinejad, et al.
Published: (2016-04-01)

Ovulation Rate after Metformin and Clomiphene vs Clomiphene Alone in Polycystic Ovary Syndrome (PCOS): A Randomized, Double-Blind, Placebo-Controlled Trial
by: Georgia Heathcote, et al.
Published: (2020-03-01)

Lean Women on Metformin and Oral Contraceptives for Polycystic Ovary Syndrome Demonstrate a Dehydrated Osteosarcopenic Phenotype: A Pilot Study
by: Charikleia Stefanaki, et al.
Published: (2019-09-01)

Ethinylestradiol<sub>30μg</sub>-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?
by: Ilie Ioana, et al.
Published: (2012-06-01)

Association between Polymorphisms of <i>OCT1</i> and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
by: Hui Hua Chang, et al.
Published: (2019-04-01)

Comparison of Metformin and Ethinyl Estradiol-Cyproterone Acetate in the Management of Polycystic Ovary Syndrome
by: Sadaf Ajaib, et al.
Published: (2018-09-01)

THE ROLE OF METFORMIN IN INDUCTION OF OVULATION IN OBESE INFERTILE PATIENTS WITH POLYCYSTIC OVARY SYNDROME
by: Huda Moosa Omran, et al.
Published: (2006-06-01)

Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome
by: Meenakumari K.J., et al.
Published: (2004-01-01)

The relationship between intestinal microbiota and polycystic ovary syndrome
by: Katarzyna Korabiusz, et al.
Published: (2019-05-01)

Metabolc aspects of polycystic ovary syndrome
by: Mojca Jensterle, et al.
Published: (2007-02-01)

Long-term results of correction of metabolic disorders in polycystic ovary syndrome after metformin treatment
by: O.O. Korytko, et al.
Published: (2019-11-01)

Comparison of effect of simvastatin and metformin monotherapy on lipid profile and testosterone levels in polycystic ovary syndrome
by: Veena Singh, et al.
Published: (2012-06-01)

Effects of Pioglitazone and Metformin on Insulin Resistance Reduction in Polycystic Ovary Syndrome: A Comparative Study
by: Amir Ziaie, et al.
Published: (2012-03-01)

Effect of metformin on early pregnancy loss in women with polycystic ovary syndrome
by: Mawahib A.S. Al-Biate
Published: (2015-06-01)

Efficacy of Vitamin D Combined with Metformin and Clomiphene in the Treatment of Patients with Polycystic Ovary Syndrome Combined with Infertility
by: Lili ZHUANG, et al.
Published: (2019-10-01)

Polycystic Ovary Syndrome in Adolescence
by: Rebecca Deans
Published: (2019-10-01)

Can sex-hormone binding globulin considered as a predictor of response to pharmacological treatment in women with polycystic ovary syndrome?
by: Ferdous Mehrabian, et al.
Published: (2013-01-01)

The Effects of Calcium-Vitamin D and Metformin on Polycystic Ovary Syndrome: A Pilot Study
by: Batool Rashidi, et al.
Published: (2009-06-01)

Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome
by: Sebastião Freitas de Medeiros
Published: (2017-12-01)

Metformin decreases miR-122, miR-223 and miR-29a in women with polycystic ovary syndrome
by: Pernille Bækgaard Udesen1, et al.
Published: (2020-12-01)

Effects of Danzhi Xiaoyao pill combined with metformin on related factors in patients with polycystic ovary syndrome
by: Shi Liang, et al.
Published: (2018-07-01)

Influence of combined oral contraceptives on polycystic ovarian morphology-related parameters in Korean women with polycystic ovary syndrome
by: Chan-Hong Park, et al.
Published: (2020-01-01)

Association of Metformin Pharmacogenetic with a Single Amino Acid Alteration in Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) Genein Patients with Polycystic Ovary Syndrome
by: Fatemeh Jafari, et al.
Published: (2019-12-01)

Changes in peripheral mitochondrial DNA copy number in metformin-treated women with polycystic ovary syndrome: a longitudinal study
by: Po-Kai Yang, et al.
Published: (2020-07-01)

Homocysteine levels in Indian women with Polycystic Ovary Syndrome
by: Mehmet Agilli, et al.
Published: (2014-10-01)

The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
by: Zeeshan Javed, et al.
Published: (2020-06-01)

Ovulation induction by metformin among obese versus non-obese women with polycystic ovary syndrome
by: Yazed Sulaiman Al-Ruthia, et al.
Published: (2017-07-01)

Estrogen Receptors in Polycystic Ovary Syndrome
by: Xue-Ling Xu, et al.
Published: (2021-02-01)

Cannot write session to /tmp/vufind_sessions/sess_v0rr8kgqc8gp7ktv1sp3ah3saa